Raphael Lis, PhD

Assistant Professor of Reproductive Medicine in Medicine

Regenerative Medicine (Medicine)

Contact & profiles

Appointments

Assistant Professor of Reproductive Medicine in MedicinePrimary
Medicine · 2019–
Assistant Professor of Reproductive Medicine
Reproductive Medicine · 2019–

Past Appointments

Show all 6

Centers

Education

Highlights

1
Proceedings of the National Academy of Sciences of the United States of America · 2021
DTDuc-Huy Tran Nguyen JZJenny Zhaoying Xiang HAHoward Alan Fine ZRZev Rosenwaks+2 more →RLRaphael Lis
PMID: 33542154PMCID: PMC7923590DOISenior author185 citations
2
Frontiers in physiology · 2021
SRShahin Rafii DRDavid Redmond RLRaphael Lis
PMID: 33868008PMCID: PMC8044318DOISenior author47 citations
3
Communications biology · 2021
RSRyan Schreiner JZJenny Zhaoying Xiang SRShahin Rafii DRDavid Redmond RLRaphael Lis
PMID: 33767339PMCID: PMC7994450DOISenior author15 citations

3 grants

Co-I
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
National Heart, Lung, and Blood Institute · 2021–2027
R33HL154310-05
Co-I
Adaptable tissue-specific endothelial cells for organ regeneration
National Heart, Lung, and Blood Institute · 2020–2027
R35HL150809-01
Sub-PI
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB model
National Heart, Lung, and Blood Institute · 2021–2026 · via Columbia University
R61HL159949-02

Completed grants (5)

Co-I
De novo generation of pre-clinical grade engraftable hematopoietic stem cells from nonhuman primate endothelium
Daedalus Fund for Innovation (Weill Cornell) · 2018–2020
DFI 200276-01
Co-I
Molecular Determinants of endothelial transition into engraftable hematopoietic cells
National Heart, Lung, and Blood Institute · 2018–2020
R01HL139056-01A1
Co-I
Conversion of Human Adult Endothelium Into Hematopoietic Stem Cells for Immune Cell Engineering
Tri-Institutional Stem Cell Initiative (Weill Cornell) · 2016–2019
2016-013
PI
Engineering Antologous Reprogrammed Hematopoietic Stem Cells for Treatment of Hemoglobinopathies
New York Stem Cell Foundation Inc. · 2017–2018
NYSCF-D-F56
KP
Evaluation of Pluripotent Stem Cell-Derived Blood Cells in Nonhuman Primates
National Heart, Lung, and Blood Institute · 2013–2017 · via Fred Hutchinson Cancer Research Center
R01HL115128-04

Molecular Sleuthing Identifies and Corrects Major Flaws in Blood-Brain Barrier Model Derived from Pluripotent Stem Cells
February 4, 2021
A type of cell derived from human stem cells that has been widely used for brain research and drug development may have been leading researchers astray for years, according to a study from scientists at Weill Cornell Medicine and Columbia University Irving Medical Center.